|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-10-26
|
|
pubmed:abstractText |
Despite the popularity of coronary stenting in coronary artery disease (CAD), restenosis remains a challenging clinical problem. This study evaluated the efficacy of rosiglitazone for preventing in-stent restenosis in type 2 diabetic patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2654-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15505001-Adult,
pubmed-meshheading:15505001-Aged,
pubmed-meshheading:15505001-Coronary Angiography,
pubmed-meshheading:15505001-Coronary Restenosis,
pubmed-meshheading:15505001-Coronary Stenosis,
pubmed-meshheading:15505001-Diabetes Mellitus, Type 2,
pubmed-meshheading:15505001-Diabetic Angiopathies,
pubmed-meshheading:15505001-Female,
pubmed-meshheading:15505001-Humans,
pubmed-meshheading:15505001-Hypoglycemic Agents,
pubmed-meshheading:15505001-Male,
pubmed-meshheading:15505001-Middle Aged,
pubmed-meshheading:15505001-Stents,
pubmed-meshheading:15505001-Thiazolidinediones,
pubmed-meshheading:15505001-Treatment Outcome,
pubmed-meshheading:15505001-Vasodilator Agents
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.
|
|
pubmed:affiliation |
Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemoon-Ku, Seoul 120-749, Korea. bscha@yumc.yonsei.ac.kr.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
